Om episode
As demand for the new class of GLP-1 weight-loss drugs skyrockets, one thing has stood in the way of many people trying to access them: cost. With a price tag around $1,000 a month for U.S. patients and many insurance companies refusing to cover these drugs for weight loss, patients are often turning to alternatives. In episode two of “Trillion Dollar Shot,” we look at the roadblocks to making these drugs more affordable, concerns that their high cost will negatively impact U.S. insurance systems, and the sometimes risk-laden options people are turning to in desperation. Listen: Trillion Dollar Shot, Episode 1: Birth of a Blockbuster Learn more about your ad choices. Visit megaphone.fm/adchoices
Nyeste episoder
The Journal.
Trillion Dollar Shot, Episode 3: Brad
2024-06-02 • 48min
The Journal.
The Origin Story of Trump's Guilty Verdict
2024-05-31 • 24min
The Journal.
The Big Short: China Edition
2024-05-30 • 24min
The Journal.
The Trustbuster Taking on Ticketmaster
2024-05-29 • 21min
The Journal.
$2.8 Billion for College Athletes and a New World for the NCAA
2024-05-28 • 18min
The Journal.
Introducing Science Vs - Ozempic: Is It Scarier Than We Thought?
2024-05-26 • 42min
The Journal.
The First Person to Get Elon Musk’s Neuralink Brain Chip
2024-05-24 • 20min
The Journal.
Could Paris Hilton Create the 'Next Disney?'
2024-05-23 • 27min
The Journal.
Years After Surfside Collapse, Florida Condos Are In Crisis
2024-05-22 • 21min
The Journal.
Why Israel and Hamas Could Be Headed Into a Forever War
2024-05-21 • 19min